I'm a bit unclear on how or why you think a reverse merger might be in the cards - especially if there is not enough good data for approval of Multikine by the FDA as our Phase III trial finishes up.
Isn't a reverse merger generally a way for a privately held company to go public by merging itself with an existing publically held shell of a company? In my experience, where I have seen a reverse merger done, it was done by a privately held company, by taking over the legal shell of an otherwise inactive or bankrupt company that wasn't actively doing any business.
CVM is still pretty active, and if they do win a sizable return from the Arbitration, then CVM most certainly won't be bankrupt. The stock price would be in a relatively sad and unstable place if Multikine does come up short for FDA approval, but they wouldn't be a defunct shell that has no outstanding business.
CVM would also still have the L.E.A.P.s platform they could develop IF they had some cash in hand. Years more delay before a product,... but also low capital burn while they develop it.
Why would some privately held company want to go public through CVM? Typically (in my limited understanding of the process) the privately held company is also looking for a shell to RM through that is clean, untainted by scandal or potential lawsuits, and that won't be controversial or cause them legal headaches down the line.
IMO - CVM doesn't fit that model very well.
I'm not trying to sound adversarial - I just don't see why this might be a likely outcome? Especially IF CVM finds itself awash in cash from an Arbitration.
News 
Market Data 
Discover 
